December 6 2024 - FDA outlines accelerated review guidelines in waning days of Biden administration

FDA outlines accelerated review guidelines in waning days of Biden administration
Teva announces agreement to divest Teva-Takeda, its business venture in Japan
Chasing Merck, BioNTech and DualityBio post first clinical data on ADC
What can we learn from 2024’s biotech IPOs?
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

*please scroll down for all the latest news*